Abstract OT-13-09: Translational breast cancer research consortium 044 trial: Randomized phase 2 study of pembrolizumab and carboplatin versus carboplatin alone for chest wall recurrence of breast cancer

A randomized phase 2 study exploring the role of bevacizumab and a chemotherapy-free approach in HER2-positive metastatic breast cancer: The HAT study (BOOG 2008-2003), a Dutch Breast Cancer Research Group trial

Cancer ◽

10.1002/cncr.30141 ◽

2016 ◽

Vol 122 (19) ◽

pp. 2961-2970 ◽

Cited By ~ 5

Author(s):

Jan C. Drooger ◽

Harm van Tinteren ◽

Steffen M. de Groot ◽

Albert J. ten Tije ◽

Hiltje de Graaf ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Research ◽

Metastatic Breast Cancer ◽

Metastatic Breast ◽

Phase 2 ◽

Her2 Positive ◽

Phase 2 Study ◽

Group Trial ◽

Abstract OT2-04-05: Pembrolizumab in combination with carboplatin versus carboplatin alone in breast cancer patients with chest wall disease: Translational Breast Cancer Research Consortium (TBCRC) 44 trial

10.1158/1538-7445.sabcs19-ot2-04-05 ◽

2020 ◽

Author(s):

Neelima Vidula ◽

Rita Nanda ◽

Kathy Miller ◽

Vandana Abramson ◽

Paula Pohlmann ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Research ◽

Cancer Patients ◽

Chest Wall ◽

Breast Cancer Research ◽

Breast Cancer Patients ◽

Abstract PD3-01: Results from KATE2, a randomized phase 2 study of atezolizumab (atezo)+trastuzumab emtansine (T-DM1) vs placebo (pbo)+T-DM1 in previously treated HER2+ advanced breast cancer (BC)

10.1158/1538-7445.sabcs18-pd3-01 ◽

2019 ◽

Cited By ~ 14

Author(s):

LA Emens ◽

F Esteva ◽

M Beresford ◽

C Saura ◽

M De Laurentiis ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Advanced Breast ◽

Trastuzumab Emtansine ◽

Phase 2 ◽

Phase 2 Study ◽

Previously Treated ◽

Translational Breast Cancer Research Consortium (TBCRC) Patient Advocate Working Group (PAWG): An approach to research advocacy.

Journal of Clinical Oncology ◽

10.1200/jco.2011.29.15_suppl.e19539 ◽

2011 ◽

Vol 29 (15_suppl) ◽

pp. e19539-e19539

Author(s):

C. Chauhan ◽

M. L. Smith ◽

N. E. Carbine ◽

L. Cargen ◽

D. K. Cline ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Research ◽

Working Group ◽

Breast Cancer Research ◽

Patient Advocate ◽

Randomized phase 2 study of abiraterone acetate (AA) with or without exemestane (E) in postmenopausal patients (pts) with estrogen receptor–positive (ER+) metastatic breast cancer (MBC).

Journal of Clinical Oncology ◽

10.1200/jco.2014.32.15_suppl.519 ◽

2014 ◽

Vol 32 (15_suppl) ◽

pp. 519-519 ◽

Cited By ~ 3

Author(s):

Joyce O'Shaughnessy ◽

Mario Campone ◽

Etienne Brain ◽

Patrick Neven ◽

Daniel F. Hayes ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Metastatic Breast Cancer ◽

Metastatic Breast ◽

Abiraterone Acetate ◽

Phase 2 ◽

Phase 2 Study ◽

Estrogen Receptor Positive ◽

Metronomic treatment of vinorelbine with oral capecitabine is tolerable in the randomized Phase 2 study XeNa including patients with HER2 non-amplified metastatic breast cancer

Acta Oncologica ◽

10.1080/0284186x.2020.1851045 ◽

2020 ◽

pp. 1-8

Author(s):

Anne Sofie Brems-Eskildsen ◽

Søren Linnet ◽

Hella Danø ◽

Adam Luczak ◽

Peter Michael Vestlev ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Metastatic Breast ◽

Phase 2 ◽

Oral Capecitabine ◽

Phase 2 Study ◽

Metronomic Treatment ◽

Overall survival results from the randomized phase 2 study of palbociclib in combination with letrozole versus letrozole alone for first-line treatment of ER+/HER2− advanced breast cancer (PALOMA-1, TRIO-18)

Breast Cancer Research and Treatment ◽

10.1007/s10549-020-05755-7 ◽

2020 ◽

Vol 183 (2) ◽

pp. 419-428 ◽

Cited By ~ 1

Author(s):

Richard S. Finn ◽

Katalin Boer ◽

Igor Bondarenko ◽

Ravindranath Patel ◽

Tamas Pinter ◽

...

Keyword(s):

Breast Cancer ◽

Overall Survival ◽

Advanced Breast Cancer ◽

Advanced Breast ◽

Line Treatment ◽

Phase 2 ◽

First Line ◽

Phase 2 Study ◽

Randomized Phase 2 ◽

First Line Treatment

Patient‐reported outcomes in the Translational Breast Cancer Research Consortium

Cancer ◽

10.1002/cncr.32615 ◽

2019 ◽

Vol 126 (5) ◽

pp. 922-930

Author(s):

Deborah J. Bowen ◽

Eileen H. Shinn ◽

Sophie Gregrowski ◽

Gretchen Kimmick ◽

Laura S. Dominici ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Research ◽

Patient Reported Outcomes ◽

Breast Cancer Research ◽

Patient Reported ◽

Collecting tissue for research purposes: A survey of 16 institutions in the Translational Breast Cancer Research Consortium (TBCRC).

Journal of Clinical Oncology ◽

10.1200/jco.2011.29.15_suppl.10615 ◽

2011 ◽

Vol 29 (15_suppl) ◽

pp. 10615-10615 ◽

Cited By ~ 1

Author(s):

E. S. Frank ◽

R. T. Burns ◽

N. E. Carbine ◽

L. Cargen ◽

C. Chauhan ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Research ◽

Breast Cancer Research ◽

P4-16-05: A Randomized Phase 2 Study of a Loading Dose of Ibandronate in Patients with Bone Metastases from Breast Cancer.

10.1158/0008-5472.sabcs11-p4-16-05 ◽

2011 ◽

Author(s):

DM Ritchie ◽

C Bray ◽

P Canney

Keyword(s):

Breast Cancer ◽

Bone Metastases ◽

Loading Dose ◽

Phase 2 ◽

Phase 2 Study ◽